312
Participants
Start Date
March 31, 2005
Primary Completion Date
May 31, 2007
Escitalopram
Escitalopram 10mg per day for three weeks, 10-20mg per day for up to the remaining 5 weeks
Placebo
Placebo once daily for up to 8 weeks
University of Pennsylvania, Department of Psychiatry, Mood & Anxiety Disorders Section, Philadelphia
Drexel University College of Medicine, Friends Hospital, Philadelphia
Children's National Medical Center, Washington D.C.
Capitol Clinical Research Associates, Rockville
Pharmasite Research, Inc., Baltimore
Brighton Research Group, LLC, Virginia Beach
North Carolina Neuropsychiatry, PA, Chapel Hill
Clinical Neuroscience Solutions, Inc., Jacksonville
University of Florida - Child Study Program, Gainesville
Kolin Research Group, Winter Park
Janus Center for Psychiatric Research, West Palm Beach
Clinical Neuroscience Solutions, Memphis
University Hospitals of Cleveland, Division of Child & Adolescent Psychiatry, Cleveland
University of Cincinnati College of Medicine, Children's Hospital Medical Center, Cincinnati
Clinco, Terre Haute
Capstone Clinical Research, Libertyville
St. Charles Psychiatric Associates, Saint Charles
Psychiatric Associates, Overland
Creighton University Medical School, Department of Psychiatry, Omaha
IPS Research Company, Oklahoma City
University of Texas Southwestern Medical Center, Center for Pediatric Psychiatry, Dallas
University of Texas Medical Branch, Department of Psychiatry & Behavioral Sciences, Galveston
UCSD Outpatient Psychiatry Services, San Diego
PCSD - Feighner Research, San Diego
University of California at Davis, MIND Institute, Health Services, Sacramento
Northwest Clinical Research Center, Bellevue
CNS Research Institute, Clementon
Pulmonary and Allergy Associates, P. A., Summit
Lead Sponsor
Forest Laboratories
INDUSTRY